Karen Shemanski, DO
Otolaryngology/Facial Plastic Surgery · Allentown, PANPI 1477867786
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $320 of the $395 with a category attached, or 81.1%. 9 manufacturers reported payments, led by Acclarent, Inc at 42.6% of the total. Reporting peaked in 2019 at $201 and has fallen 62.8% since, to $75 in 2022. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in PA, where the typical reported total is $3,163.
Across 16 payments — averaging $24.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$168
- Sanofi-aventis U.S. LLC$75
- Optinose US, Inc.$59
- Sanofi$22
- Circassia Inc.$19
- Intersect ENT, Inc.$15
- plus $37 from 3 others
What the payments were for
- Food & beverage$32081%
- Education$7519%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 5 | $168 |
| Sanofi-aventis U.S. LLC | 1 | $75 |
| Optinose US, Inc. | 4 | $59 |
| Sanofi | 1 | $22 |
| Circassia Inc. | 1 | $19 |
| Intersect ENT, Inc. | 1 | $15 |
| Alk-abello, Inc | 1 | $14 |
| Novartis | 1 | $12 |
| Aytu Biopharma, Inc. | 1 | $11 |
How this compares
$395 in reported general payments places this provider in the 20th percentile of 21 otolaryngology/facial plastic surgery providers in Pennsylvania.
See all otolaryngology/facial plastic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 121 | $3,298 |
| Ofloxacin | 50 | $1,208 |
| Doxycycline Monohydrate | 30 | $655 |
| Fluocinolone Acetonide Oil | 19 | $636 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 53 | $574 |
| Ipratropium Bromide | 18 | $537 |
| Methylprednisolone | 50 | $281 |
| Famotidine | 38 | $240 |
| Montelukast Sodium | 18 | $218 |
| Prednisone | 71 | $179 |
| Fluticasone Propionate | 13 | $143 |
| Mupirocin | 24 | $134 |
| Azithromycin | 14 | $95 |
| Amoxicillin | 20 | $34 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Allentown
- Jason BloomBryn Mawr$718K
- Donald SessoNorristown$23K
- Sean CarrollErie$6K
- Melissa SchwartzElkins Park$5K
- Adam MariottiExton$5K
- Jeffrey BrigliaLanghorne$4K
- Aykut UnsalPhiladelphia$4K
- Michael PicarielloExton$4K
- Raphael GabayPhiladelphia$4K
- Jose UribeBethlehem$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.